Stay informed with the latest litigation news. Explore now

Ipsen Pharma S.a.s. patent opposition analysis

Get complete Patent Opposition Report for Ipsen Pharma S.a.s.

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Ipsen Pharma S.a.s. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
Lyophilized Preparation Of Botulinum ToxinMEDY TOXFeb 2, 2018

Explore Ipsen Pharma S.a.s.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 17, 2017A Stable Composition Comprising Pthrp And Uses Thereof2
Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo Biloba1